During the last year, over 4,500 initial crystallisation screens were used at the LMB to test macromolecular samples of interest. Further screens are often required for optimisation purposes. The corresponding trays containing the crystallisation experiments are stored in temperature-controlled rooms as seen here on day 298 of #LMB365.
LMB 365 – Day 298
LMB 365 – Day 297
Day 297 of #LMB365 is a screenshot from our internal “Bee Cam”. It shows our resident beekeeper Geoff putting on a feeder of sugar syrup for the LMB’s bees to build up stores for the winter. The bees have also been treated for mites so hopefully they will be well until next year.
LMB researchers share their science in Cambridge, Ely and Peterborough
LifeLab returned for the second year of the project – this time with LMB scientists taking their research to Ely Cathedral and Queensgate Shopping Centre in Peterborough, as well as to events in Cambridge. Through a range of hands-on activities, talks, discussions, displays, and entertainment, LifeLab volunteers talked to more than 3,500 people across Cambridge, Ely, and Peterborough over a day and a half.
LMB 365 – Day 296
The annual Perutz Student Prize has been awarded recently and the winners photographed in the Max Perutz Lecture Theatre under Max’s watchful eye as recorded here on day 296 of #LMB365 by Anne Bertolotti. Watch this space to find out about the winners…
Michel Goedert receives the first Rainwater Prize for Outstanding Innovation in Neurodegenerative Research
The Rainwater Prize Program, the largest prize program for brain research based in Texas, US, has conferred its inaugural award to Michel Goedert. Michel, in the LMB’s Neurobiology Division, received the Prize for establishing that the abnormal assembly of Tau protein is central to a large number of neurodegenerative diseases, including Alzheimer’s Disease. “The Rainwater Prize […]
LMB 365 – Day 295
Day 295 of #LMB365 shows the structure of a human GABAA receptor in a membrane nanodisc, bound to alprazolam/Xanax, solved in Radu Aricescu’s group. GABAA receptors are essential for brain function and also targets for major clinical drugs including general anaesthetics, benzodiazepines and sleeping pills.